Figure 2.

The Cystic Fibrosis Foundation Therapeutics Pipeline as it currently stands. These are CF therapies in various stages of development with the support of the Cystic Fibrosis Foundation. The therapies discussed in this article are those under the categories labeled “CFTR Modulation,” “Restore Airway Surface Liquid,” “Mucus Alteration,” “Anti-inflammatory,” and “Anti-infective” and for which there are published phase 2, and in certain cases phase 1, data available. See Figure 1 legend for expansion of abbreviations. (Reprinted with permission from the Cystic Fibrosis Foundation; interactive version available.²)